Skip to main content

Exeter academic wins renowned cancer research award

An Exeter paper has won Research Paper of the Year under the cancer category in the Royal College for General Practitioners (RCGP) Research Awards.

Rare cancer could be caught early using simple blood tests

A pioneering study into myeloma, a rare cancer, could lead to GPs using simple blood tests to improve early diagnosis.

Exeter leads early cancer diagnosis in major policy centre

A national expert on cancer diagnosis will take a lead role in a new £4.75 million centre to create research that guides policy.

Testicular cancer study reveals highest risk symptoms to aid diagnosis

A new study has identified the highest risk symptoms that can indicate testicular cancer, in research that aims to improve diagnosis.

Exeter wins £1.5m funding for world-leading initiative to advance health research

The University of Exeter has been awarded £1.5 million by Wellcome to enable translation of findings from its world-leading research programmes into improvements in human health on a global scale.

Cancer paper wins “Research Paper of the Year”

A research paper published in 2014 by the University of Exeter, working with researchers from the University of Bristol’s Centre for Academic Primary Care and Cambridge University, has won Research Paper of the Year Award 2014 from the Royal College of General Practitioners (RCGP).

Exeter expertise helps underpin new cancer guidelines

Research by the University of Exeter has helped underline new national guidelines to help GPs diagnose cancer earlier, and save lives.

Persistent swollen neck glands could indicate cancer

Referring patients with unexplained swollen neck glands for specialist investigations could help to avoid some of the thousands of deaths each year from lymphoma, a type of cancer.

Black men less willing to be investigated for prostate cancer

The incidence of prostate cancer among men of Afro-Caribbean origin is higher than in white men, they are more likely to be diagnosed as emergencies and their mortality rates are higher. Until now it has been unclear why these disappointing outcomes exist.